From: "Paolo Grassi" <pg@jesmond.com>
To: <info@terviseamet.ee>
Subject: BPR fees for biocide PT18 and PT19
Date: Wed, 30 Jul 2025 11:59:37 +0300
Message-ID: <PR3P193MB08302D5905B39F0D3DAF1CD8D624A@PR3P193MB0830.EURP193.PROD.OUTLOOK.COM>
MIME-Version: 1.0
Content-Type: multipart/related;
	boundary="----=_NextPart_000_0039_01DC0157.DF381790"
Thread-Index: AQIUzqTxLxgE+W+3jQxqYnmk180wtA==
x-ms-exchange-antispam-messagedata-chunkcount: 1
x-ms-exchange-antispam-messagedata-0: =?iso-8859-1?Q?UUr27wUJTkMUmxT1vlj7oCRlJzHqyTJwiHcgNAWwi4y0AFqY+Z3/db4HX8?=
 =?iso-8859-1?Q?CU8BBJcmqES3mw5MAh7yt1S430DbygwEUvHMdlQ5NcAYQ54RYPGbprF3jO?=
 =?iso-8859-1?Q?QST9jpa0dhN72eKsrPF8Xncl/ev1by6T+NyGJpLaT2ALx8hjy0OdeQGxvP?=
 =?iso-8859-1?Q?QV3lgycwPgBAZeltOES/zAWnwGb6ZGBflr884nEkqJXSci4YUrGctMNRwi?=
 =?iso-8859-1?Q?Zosb4x9cUJ1JH2PBgwgYigrmPGu2xoQ5fByCPGUaPpYVdg+et0VeWjOy4m?=
 =?iso-8859-1?Q?VGNQUj8y8/P+WwFvF27QlIdiS64LVct2HNkoV92LWXpQRF+9mL5KZUVLTY?=
 =?iso-8859-1?Q?vtSoLevAWSoqztgSJcRSuX78TT86To0uM7sfsdA5Rb4vRL46SyjWo3J/UF?=
 =?iso-8859-1?Q?ixK8eFvX1M+Xy9nx05ulBZ2MbHqdQDfMn11G5KE79S1v+gTQD3dKzMu5OX?=
 =?iso-8859-1?Q?G96HR7sHPar4YQRCjQ1l7WlBbIgYhWC9rxtWJ6WJdjPAEUntCm09FONJaR?=
 =?iso-8859-1?Q?6bY2UIPlYtIOt/ZOIzslM+ILmzeVVL6dcR9UyrAVWGvuMlWusoMVKsWPyn?=
 =?iso-8859-1?Q?eRWdKk4YNll/u9mT/2fepkf6WyrbkqjEySgJvXpKC4SahEAZEdM0pWpYTc?=
 =?iso-8859-1?Q?ChRvB5OgVwdZSBn9HBzss7ML8dprqI3LwfqrcOCQ963fMLXZFyyw8B23FR?=
 =?iso-8859-1?Q?dTGmWr0OiTT7XoDc9ISMgrHbTTt5biQ8K9/wqzuQIOkAfHExh
	+3pUjDtsn?=
 =?iso-8859-1?Q?od6MaEabu0RCO76Vu+yXdyJaygk8Xkb15mhAqizzVE7vyj4Z9Xu75CdrAS?=
 =?iso-8859-1?Q?xy5XrcUYq4/U7nlxP8Bb/NbdH/r358ltqahrXOehgX311/zlkoBSNyNZy7?=
 =?iso-8859-1?Q?MB1ysOpy7yJWKSZBkGxh584U0A+pnYogxuXIDEQ1PRmXfH/FOn+ENaPmsE?=
 =?iso-8859-1?Q?/RBWQJiC+ieynfmGEqzeEQfPf2wnf/4zavKeL7XkyUGjScc8WitXFFahnI?=
 =?iso-8859-1?Q?APQb/1KKJcQfk5ADqfY0qu3e5RZLo7WjbPQsR8Crljia6EG4J8Xq7Wt/Xy?=
 =?iso-8859-1?Q?CmGOaFsW40vzNYpvBUeeCmr8lxCwJh4sOzCujnDYXL9Fg1Y7mLsXa6itfk?=
 =?iso-8859-1?Q?hx6jjjO0mg9bBEyvAriUGytEuH73uk75qWLzrjjClRHsXDiMrRYtj/RTFK?=
 =?iso-8859-1?Q?WZp/e0Tk1ujkwMrFHZoPnUE0LmaeWVYxmLUV90f5xkWtqDKlV9qia39cHi?=
 =?iso-8859-1?Q?WlGDuQQOp9+6hJVUJAWmoJ1aj+W2ZJF/I11a8f8m0o4WaUj+ojkQLsBMzs?=
 =?iso-8859-1?Q?u+DpdhwgkF7oLugNHK0BREMMOY+sIM528K4Ig5WsaBZhcYp7DIx5u063G+?=
 =?iso-8859-1?Q?O/SJA7wcKuv+aIUpIXOv/U/jhQ6DSGQ+FwOGc3xRSkDufG7lm1RFV+RSd5?=
 =?iso-8859-1?Q?N9FQGX2+ERZDIqN4RVsLYw2qbNTNMSz+aD3XbSVHhCXPeLz6nH7bb57ucX?=
 =?iso-8859-1?Q?KjW5Okxg8Gzh4TORXYAmsEVjaK/MUydl/JL
	dWtWYG8KM66AeO2MGcNmpD/?=
 =?iso-8859-1?Q?PqlS3XF0LuxrVvZkHxhv6AYLAXdOmjNf4enSYuE2K7n1bBmOWiiwGJuHwf?=
 =?iso-8859-1?Q?mbbc5Bde6C+gg=3D?=
X-MS-Exchange-CrossTenant-AuthAs: Internal
X-MS-Exchange-CrossTenant-AuthSource: PR3P193MB0830.EURP193.PROD.OUTLOOK.COM
X-MS-Exchange-CrossTenant-Network-Message-Id: 56f09fb5-2dac-4e1f-e220-08ddcf47696b
X-MS-Exchange-CrossTenant-originalarrivaltime: 30 Jul 2025 08:59:37.4592
 (UTC)
X-MS-Exchange-CrossTenant-fromentityheader: Hosted
X-MS-Exchange-CrossTenant-id: ceb631b7-c385-4df6-a310-208bb2a4a7ae
X-MS-Exchange-CrossTenant-mailboxtype: HOSTED
X-MS-Exchange-CrossTenant-userprincipalname: 0TnOn9Ot1TniFN5Mpe4/pu4UJKzpcbE0T/Ua/cwKI+7zW7VT1oKYmStW6bjWx+hmT94KW1Frs+PqjfHJu7cahg==
X-MS-Exchange-Transport-CrossTenantHeadersStamped: DB8P193MB0744
X-MS-Exchange-Organization-Network-Message-Id: 15723f93-9972-494d-844d-08ddcf476c5f
X-MS-Exchange-Organization-AVStamp-Enterprise: 1.0
X-MS-Exchange-Organization-AuthSource: TEHIK-EX01.sotsiaalministeerium.ee
X-MS-Exchange-Organization-AuthAs: Anonymous
X-MS-Exchange-Transport-EndToEndLatency: 00:00:00.6538728
X-MS-Exchange-Processed-By-BccFoldering: 15.01.2507.057
X-OlkEid: 00000000C2F100042791FD488835E929BC7E6508070034AD76187591974DBF6C4F76951C873A0100020000000000FEAC6C021EAD0E46B13124BDE57E2D4F00000000155800006C2407B3826E344F8E3C9DB70370B87F

This is a multipart message in MIME format.

------=_NextPart_000_0039_01DC0157.DF381790
Content-Type: multipart/alternative;
	boundary="----=_NextPart_001_003A_01DC0157.DF381790"


------=_NextPart_001_003A_01DC0157.DF381790
Content-Type: text/plain;
	charset="iso-8859-1"
Content-Transfer-Encoding: 8bit


Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu
saatja korral palume linke ja faile mitte avada.




Dear Health Board Estonia,



We would like to submit a biocide product according to BPR (PT18) in
February/March 2026. For this purpose, there will be a BPR fee in each
European country, apart from the ECHA fees.



Could you let us know the BPR fee for this kind of PT 18 product in your
country? And could you let us know if the costs for a PT 19 product would
be the same?



Thanks in advance,

Paolo





Dr. Paolo Grassi

Project Development Manager



 <https://www.jesmond.com/en/>

Jesmond BioScience GesmbH

Weimarerstrasse 104, 1190 Vienna/Austria

FN 94205 m  |  UID: ATU16123807  |  FB-Gericht: Handelsgericht Wien

Tel: +43 1 368 51 85 17  |  Fax: +43 1 368 00 50 | Mobile: +43 676 605
1112

Web:  <http://www.jesmond.com/> www.jesmond.com



  <https://www.linkedin.com/company/jesmond>



Save a tree, please do not print this e-mail unless necessary.

Die Informationen dieses Emails sind adressiert und vertraulich. Falls Sie
nicht der genannte Empfänger dieser Nachricht sind, ist das Öffnen,
Kopieren und Weiterleiten untersagt.

The content of this email is privileged and confidential. If you are not
the addressee indicated in this message, you may not disclose, copy or
forward this email.




------=_NextPart_001_003A_01DC0157.DF381790
Content-Type: text/html;
	type="multipart/alternative";
	boundary="_005_PR3P193MB08302D5905B39F0D3DAF1CD8D624APR3P193MB0830EURP_";
	charset="iso-8859-1"
Content-Transfer-Encoding: quoted-printable

<html xmlns:v=3D"urn:schemas-microsoft-com:vml" =
xmlns:o=3D"urn:schemas-microsoft-com:office:office" =
xmlns:w=3D"urn:schemas-microsoft-com:office:word" =
xmlns:m=3D"http://schemas.microsoft.com/office/2004/12/omml" =
xmlns=3D"http://www.w3.org/TR/REC-html40"><head>
<meta http-equiv=3D"Content-Type" content=3D"text/html; =
charset=3Diso-8859-1">
<meta name=3D"Generator" content=3D"Microsoft Word 15 (filtered =
medium)">
<!--[if !mso]><style>v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style><![endif]--><style><!--
/* Font Definitions */
@font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
	{font-family:Calibri;
	panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
	{font-family:Aptos;}
@font-face
	{font-family:"Segoe UI";
	panose-1:2 11 5 2 4 2 4 2 2 3;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
	{margin:0cm;
	font-size:12.0pt;
	font-family:"Aptos",sans-serif;
	mso-ligatures:standardcontextual;
	mso-fareast-language:EN-US;}
span.E-MailFormatvorlage17
	{mso-style-type:personal-compose;
	font-family:"Aptos",sans-serif;
	color:windowtext;}
.MsoChpDefault
	{mso-style-type:export-only;
	mso-fareast-language:EN-US;}
@page WordSection1
	{size:612.0pt 792.0pt;
	margin:70.85pt 70.85pt 2.0cm 70.85pt;}
div.WordSection1
	{page:WordSection1;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext=3D"edit" spidmax=3D"1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext=3D"edit">
<o:idmap v:ext=3D"edit" data=3D"1" />
</o:shapelayout></xml><![endif]-->
</head>
<body lang=3D"DE" link=3D"#467886" vlink=3D"#96607D" =
style=3D"word-wrap:break-word"><table class=3D"MsoNormalTable" =
border=3D"0" cellspacing=3D"0" cellpadding=3D"0" align=3D"left" =
style=3D"mso-cellspacing:0cm;mso-yfti-tbllook:1184;mso-table-lspace:2.25p=
t;
 =
mso-table-rspace:2.25pt;mso-table-anchor-vertical:paragraph;mso-table-anc=
hor-horizontal:
 column;mso-table-left:left;mso-padding-alt:0cm 0cm 0cm 0cm">
 <tbody><tr =
style=3D"mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes">
 <td width=3D"100%" =
style=3D"width:100.0%;background:#FFE599;padding:5.25pt 3.75pt 5.25pt =
11.25pt">
 <p =
style=3D"mso-element:frame;mso-element-frame-hspace:2.25pt;mso-element-wr=
ap:
 =
around;mso-element-anchor-vertical:paragraph;mso-element-anchor-horizonta=
l:
 column;mso-height-rule:exactly"><strong><span =
style=3D"font-family:&quot;Arial&quot;,sans-serif;
 color:#212121">T=E4helepanu!</span></strong><span =
style=3D"font-family:&quot;Arial&quot;,sans-serif;
 color:#212121"> Tegemist on v=E4ljastpoolt asutust saabunud kirjaga. =
Tundmatu
 saatja korral palume linke ja faile mitte avada. </span><o:p></o:p></p>
 </td>
 </tr>
</tbody></table><br><span>&nbsp;</span>
<div class=3D"WordSection1">
<p class=3D"MsoNormal">Dear Health Board Estonia,<o:p></o:p></p>
<p class=3D"MsoNormal"><o:p>&nbsp;</o:p></p>
<p class=3D"MsoNormal"><span lang=3D"EN-US">We would like to submit a =
biocide product according to BPR (PT18) in February/March 2026. For this =
purpose, there will be a BPR fee in each European country, apart from =
the ECHA fees.<o:p></o:p></span></p>
<p class=3D"MsoNormal"><span lang=3D"EN-US"><o:p>&nbsp;</o:p></span></p>
<p class=3D"MsoNormal"><span lang=3D"EN-US">Could you let us know the =
BPR fee for this kind of PT 18 product in your country? And could you =
let us know if the costs for a PT 19 product would be the same?
<o:p></o:p></span></p>
<p class=3D"MsoNormal"><span lang=3D"EN-US"><o:p>&nbsp;</o:p></span></p>
<p class=3D"MsoNormal"><span lang=3D"EN-US">Thanks in =
advance,<o:p></o:p></span></p>
<p class=3D"MsoNormal"><span lang=3D"EN-US">Paolo<o:p></o:p></span></p>
<p class=3D"MsoNormal"><span lang=3D"EN-US"><o:p>&nbsp;</o:p></span></p>
<p class=3D"MsoNormal"><span lang=3D"EN-US"><o:p>&nbsp;</o:p></span></p>
<p class=3D"MsoNormal"><b><span lang=3D"EN-GB" =
style=3D"font-size:9.0pt;font-family:&quot;Segoe =
UI&quot;,sans-serif;color:#1F3864;mso-fareast-language:DE-AT">Dr. Paolo =
Grassi</span></b><span lang=3D"EN-GB" style=3D"font-family:&quot;Segoe =
UI&quot;,sans-serif;color:#1F3864;mso-fareast-language:DE-AT"><o:p></o:p>=
</span></p>
<p class=3D"MsoNormal"><span lang=3D"EN-GB" =
style=3D"font-size:9.0pt;font-family:&quot;Segoe =
UI&quot;,sans-serif;color:#1F3864;mso-fareast-language:DE-AT">Project =
Development Manager<o:p></o:p></span></p>
<p class=3D"MsoNormal"><span lang=3D"EN-GB" =
style=3D"font-size:9.0pt;font-family:&quot;Segoe =
UI&quot;,sans-serif;color:#1F3864;mso-fareast-language:DE-AT"><o:p>&nbsp;=
</o:p></span></p>
<p class=3D"MsoNormal"><a href=3D"https://www.jesmond.com/en/"><span =
lang=3D"DE-AT" style=3D"font-family:&quot;Segoe =
UI&quot;,sans-serif;color:windowtext;mso-fareast-language:DE-AT;text-deco=
ration:none"><img border=3D"0" width=3D"147" height=3D"25" =
style=3D"width:1.5333in;height:.2583in" id=3D"Bild_x0020_1" =
src=3D"cid:image001.jpg@01DC0140.853A7DD0"></span></a><span =
style=3D"font-size:8.0pt;font-family:&quot;Segoe =
UI&quot;,sans-serif;color:#1F3864;mso-fareast-language:DE-AT"><o:p></o:p>=
</span></p>
<p class=3D"MsoNormal"><b><span lang=3D"EN-GB" =
style=3D"font-size:8.0pt;font-family:&quot;Segoe =
UI&quot;,sans-serif;color:#1F3864;mso-fareast-language:DE-AT">Jesmond =
BioScience GesmbH<o:p></o:p></span></b></p>
<p class=3D"MsoNormal"><span lang=3D"EN-GB" =
style=3D"font-size:8.0pt;font-family:&quot;Segoe =
UI&quot;,sans-serif;color:#1F3864;mso-fareast-language:DE-AT">Weimarerstr=
asse 104, 1190 Vienna/Austria<o:p></o:p></span></p>
<p class=3D"MsoNormal"><span lang=3D"DE-CH" =
style=3D"font-size:8.0pt;font-family:&quot;Segoe =
UI&quot;,sans-serif;color:#1F3864;mso-fareast-language:DE-AT">FN 94205 =
m&nbsp; |&nbsp;
</span><span style=3D"font-size:8.0pt;font-family:&quot;Segoe =
UI&quot;,sans-serif;color:#1F3864;mso-fareast-language:DE-AT">UID: =
ATU16123807&nbsp; |&nbsp; FB-Gericht: Handelsgericht =
Wien<o:p></o:p></span></p>
<p class=3D"MsoNormal"><span lang=3D"EN-US" =
style=3D"font-size:8.0pt;font-family:&quot;Segoe =
UI&quot;,sans-serif;color:#1F3864;mso-fareast-language:DE-AT">Tel: =
&#43;43 1 368 51 85 17&nbsp; |&nbsp; Fax: &#43;43 1 368 00 50 | Mobile: =
&#43;43 676 605 1112<o:p></o:p></span></p>
<p class=3D"MsoNormal"><span lang=3D"EN-US" =
style=3D"font-size:8.0pt;font-family:&quot;Segoe =
UI&quot;,sans-serif;color:#1F3864;mso-fareast-language:DE-AT">Web:</span>=
<span lang=3D"EN-US" style=3D"font-size:8.0pt;font-family:&quot;Segoe =
UI&quot;,sans-serif;color:#4472C4;mso-fareast-language:DE-AT">
</span><span lang=3D"DE-AT" style=3D"mso-fareast-language:DE-AT"><a =
href=3D"http://www.jesmond.com/"><span lang=3D"EN-US" =
style=3D"font-size:8.0pt;font-family:&quot;Segoe =
UI&quot;,sans-serif;color:#4472C4">www.jesmond.com</span></a></span><span=
 lang=3D"EN-US" style=3D"font-size:8.0pt;font-family:&quot;Segoe =
UI&quot;,sans-serif;color:#4472C4;mso-fareast-language:DE-AT">&nbsp;&nbsp=
;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
 =
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<o:p></o:p></span><=
/p>
<p class=3D"MsoNormal"><span lang=3D"DE-AT" =
style=3D"font-size:11.0pt"><o:p>&nbsp;</o:p></span></p>
<p class=3D"MsoNormal"><span lang=3D"EN-US" =
style=3D"mso-fareast-language:DE-AT">&nbsp;</span><a =
href=3D"https://www.linkedin.com/company/jesmond"><span lang=3D"DE-AT" =
style=3D"font-family:&quot;Segoe =
UI&quot;,sans-serif;color:#0563C1;mso-fareast-language:DE-AT;text-decorat=
ion:none"><img border=3D"0" width=3D"31" height=3D"29" =
style=3D"width:.325in;height:.3in" id=3D"Bild_x0020_2" =
src=3D"cid:image002.png@01DC0140.853A7DD0"></span></a><span =
lang=3D"EN-US" =
style=3D"font-family:&quot;Calibri&quot;,sans-serif;mso-fareast-language:=
DE-AT"><o:p></o:p></span></p>
<p class=3D"MsoNormal"><b><span lang=3D"EN-US" =
style=3D"font-size:8.0pt;font-family:&quot;Segoe =
UI&quot;,sans-serif;color:green;mso-fareast-language:DE-AT"><o:p>&nbsp;</=
o:p></span></b></p>
<p class=3D"MsoNormal"><b><span lang=3D"EN-US" =
style=3D"font-size:8.0pt;font-family:&quot;Segoe =
UI&quot;,sans-serif;color:green;mso-fareast-language:DE-AT">Save a tree, =
please do not print this e-mail unless necessary.</span></b><b><span =
lang=3D"EN-US" style=3D"font-size:8.0pt;font-family:&quot;Segoe =
UI&quot;,sans-serif;color:#002060"><o:p></o:p></span></b></p>
<p class=3D"MsoNormal"><span =
style=3D"font-size:8.0pt;font-family:&quot;Segoe =
UI&quot;,sans-serif;color:#002060;mso-fareast-language:DE-AT">Die =
Informationen dieses Emails sind adressiert und vertraulich. Falls Sie =
nicht der genannte Empf=E4nger dieser Nachricht sind, ist
 das =D6ffnen, Kopieren und Weiterleiten untersagt. =
<o:p></o:p></span></p>
<p class=3D"MsoNormal"><span lang=3D"EN-GB" =
style=3D"font-size:8.0pt;font-family:&quot;Segoe =
UI&quot;,sans-serif;color:#002060;mso-fareast-language:DE-AT">The =
content of this email is privileged and confidential. If you are not the =
addressee indicated in this message, you
 may not disclose, copy or forward this email.<o:p></o:p></span></p>
<p class=3D"MsoNormal"><span lang=3D"EN-US"><o:p>&nbsp;</o:p></span></p>
</div>
</body>
</html>

------=_NextPart_001_003A_01DC0157.DF381790--

------=_NextPart_000_0039_01DC0157.DF381790
Content-Type: image/jpeg;
	name="image001.jpg"
Content-Transfer-Encoding: base64
Content-ID: <image001.jpg@01DC0140.853A7DD0>
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------=_NextPart_000_0039_01DC0157.DF381790
Content-Type: image/png;
	name="image002.png"
Content-Transfer-Encoding: base64
Content-ID: <image002.png@01DC0140.853A7DD0>
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------=_NextPart_000_0039_01DC0157.DF381790--